Logo image of COO

COOPER COS INC/THE (COO) Stock Price, Forecast & Analysis

USA - Nasdaq - NASDAQ:COO - US2166485019 - Common Stock

80.61 USD
-1.76 (-2.14%)
Last: 1/20/2026, 8:00:01 PM
80.61 USD
0 (0%)
After Hours: 1/20/2026, 8:00:01 PM

COO Key Statistics, Chart & Performance

Key Statistics
Market Cap16.03B
Revenue(TTM)4.09B
Net Income(TTM)374.90M
Shares198.81M
Float197.58M
52 Week High100.24
52 Week Low61.78
Yearly Dividend0
Dividend Yield0.02%
EPS(TTM)4.13
PE19.52
Fwd PE17.66
Earnings (Next)03-04
IPO1983-01-21
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Supplies
COO short term performance overview.The bars show the price performance of COO in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 2 -2 4 6 8

COO long term performance overview.The bars show the price performance of COO in the last 1, 2 and 3 years. 1 year 2 years 3 years -5 -10 -15

The current stock price of COO is 80.61 USD. In the past month the price decreased by -2.24%. In the past year, price decreased by -17.49%.

COOPER COS INC/THE / COO Daily stock chart

COO Technical Analysis

ChartMill assigns a technical rating of 5 / 10 to COO. When comparing the yearly performance of all stocks, COO is a bad performer in the overall market: 69.48% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating

COO Fundamental Analysis

ChartMill assigns a fundamental rating of 5 / 10 to COO. While COO has a great profitability rating, there are some minor concerns on its financial health.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

COO Financial Highlights

Over the last trailing twelve months COO reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS increased by 11.62% compared to the year before.


Industry RankSector Rank
PM (TTM) 9.16%
ROA 3.02%
ROE 4.55%
Debt/Equity 0.3
Chartmill High Growth Momentum
EPS Q2Q%10.58%
Sales Q2Q%4.6%
EPS 1Y (TTM)11.62%
Revenue 1Y (TTM)5.06%

COO Forecast & Estimates

23 analysts have analysed COO and the average price target is 92.56 USD. This implies a price increase of 14.83% is expected in the next year compared to the current price of 80.61.

For the next year, analysts expect an EPS growth of 10.55% and a revenue growth 5.64% for COO


Analysts
Analysts75.65
Price Target92.56 (14.82%)
EPS Next Y10.55%
Revenue Next Year5.64%

COO Ownership

Ownership
Inst Owners106.05%
Ins Owners0.61%
Short Float %4%
Short Ratio2.77

About COO

Company Profile

COO logo image The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.

Company Info

COOPER COS INC/THE

6101 Bollinger Canyon Road, Suite 500

San Ramon CALIFORNIA 94583 US

CEO: Albert G. White III

Employees: 15000

COO Company Website

COO Investor Relations

Phone: 19254603600

COOPER COS INC/THE / COO FAQ

What does COOPER COS INC/THE do?

The Cooper Cos, Inc. operates as a medical device company. The company is headquartered in San Ramon, California and currently employs 15,000 full-time employees. The firm operates in two business units: CooperVision and CooperSurgical. CooperVision segment is involved in the contact lens industry. CooperSurgical segment is involved in the fertility and women's health care market through its diversified portfolio of products and services, including fertility products and services, medical devices, cryostorage (such as cord blood and cord tissue storage) and contraception. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys. CooperSurgical’s portfolio includes INSORB, Lone Star, and the Doppler Blood Flow Monitor. The company also offers a suite of single-use cordless surgical retractors with an integrated multi-light-emitting diode (LED) light source and dual smoke evacuation channels, and single-use surgical suction devices with an integrated, cordless radial LED light source.


What is the current price of COO stock?

The current stock price of COO is 80.61 USD. The price decreased by -2.14% in the last trading session.


Does COO stock pay dividends?

COOPER COS INC/THE (COO) has a dividend yield of 0.02%. The yearly dividend amount is currently 0.


What is the ChartMill rating of COOPER COS INC/THE stock?

COO has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 5 out of 10.


Can you provide the sector and industry classification for COOPER COS INC/THE?

COOPER COS INC/THE (COO) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


What is the market capitalization of COO stock?

COOPER COS INC/THE (COO) has a market capitalization of 16.03B USD. This makes COO a Large Cap stock.


What is the outstanding short interest for COOPER COS INC/THE?

The outstanding short interest for COOPER COS INC/THE (COO) is 4% of its float.